Clinical

Advocate Health Care informaticist says there are both challenges and opportunities for as technology becomes more widely used in clinical settings.

CRISPR has sparked considerable excitement for precision medicine, but patient safety, enzyme delivery and today’s level of disease understanding are limiting mainstream adoption.

But the looming shortage of data scientists will likely slow down the adoption, CMO says.

Partnership with MAP Health Management will help identify people at risk of relapse so healthcare providers can intervene sooner.

On June 8 at 1 p.m. EST, Healthcare IT News and NewYork-Presbyterian Hospital will co-host an inaugural #HealthyTechTalk Twitter Chat to explore the state of digital health and its opportunities to improve care delivery.

New cancer test requires less DNA than previous versions.

Officials at New Jersey Diamond Institute for Fertility and Menopause say they don’t know when the initial breach began.

More than 400 pieces of technology have already been distributed to hospitals across the country.

While tests like those offered by 23andMe help patients become proactive in their healthcare, providers and the industry aren’t ready to interpret them.

Jeff Gordon & Sohn Precision Medicine Fund at Memorial Sloan Kettering Cancer Center is funded by a $200,000 grant to combat cancer in children.